Bright Minds Biosciences Inc.

DRUG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001827401

SEC filings (opens in a new tab)

No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Bright Minds Biosciences Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of DRUG: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	74	2	94	+22
Shares	6.59M	48.7K	9.19M	+2.65M (+40.5%)
Value	$514.9M	$3.80M	$670.3M	+$159.2M (+31.1%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to DRUG in Q1 2026
Institution	Shares	Value	% of portfolio
Vestal Point Capital, LP	492,319	$35.9M	1.00%
Deerfield Management Company, L.P. (Series C)	283,000	$20.7M	0.24%
Ra Capital Management, L.P.	265,000	$19.3M	0.20%
Great Point Partners LLC	220,000	$16.1M	3.93%
B Group, Inc.	67,500	$4.93M	3.65%
Vanguard Portfolio Management LLC	60,482	$4.41M	0.00%
Ameriprise Financial Inc	50,027	$3.65M	0.00%
Woodline Partners LP	45,668	$3.33M	0.01%
Parkman Healthcare Partners LLC	40,098	$2.93M	0.30%
OrbiMed Advisors LLC	40,000	$2.92M	0.07%
KVP Capital Advisors, LP	31,813	$2.32M	1.73%
SEI Investments Co	11,188	$816.4K	0.00%
Ghisallo Capital Management LLC	11,000	$802.7K	0.02%
EAM Investors, LLC	9,189	$670.5K	0.08%
Trexquant Investment LP	7,451	$543.7K	0.00%
Quadrature Capital Ltd	6,498	$474.2K	0.01%
Seven Fleet Capital Management LP	6,395	$466.6K	0.15%
Vanguard Fiduciary Trust Co	6,062	$442.3K	0.00%
DnB Asset Management AS	4,441	$324.1K	0.00%
Susquehanna International Group, LLP	3,141	$229.2K	0.00%
Vanguard Global Advisers, LLC	3,058	$223.1K	0.00%
Persistent Asset Partners Ltd	2,310	$168.6K	0.07%
Aquatic Capital Management LLC	2,045	$149.2K	0.00%
China Universal Asset Management Co., Ltd.	500	$36.5K	0.00%
GAMMA Investing LLC	33	$2.41K	0.00%
Bell Investment Advisors, Inc	6	$438	0.00%
Allworth Financial LP	3	$219	0.00%
MAI Capital Management	1	$73	0.00%
Twin Peaks Wealth Advisors, LLC	1	$73	0.00%

Sold out (7)

Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of DRUG in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
StemPoint Capital LP	97,340	$7.60M
Commodore Capital LP	18,851	$1.47M
Marshall Wace, LLP	4,600	$359.0K
Two Sigma Investments, LP	2,601	$203.0K
Advisor Group Holdings, Inc.	371	$29.0K
Amalgamated Bank	159	$12.0K
Farther Finance Advisors, LLC	39	$3.04K

Not filed for Q1 2026 yet (2)

Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DRUG in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	48,576	$3.79M
Global Retirement Partners, LLC	100	$7.80K